Chapter Fifteen - What They Built

CHAPTER FIFTEEN

What They Built

IT WAS NEVER just about the drug.

OxyContin was the product.
But pain was the raw material.
Trust was the currency.
And addiction was the engine.

What Purdue built wasn’t a pill.

It was a machine.

A machine that turned human suffering into quarterly revenue.

It extracted stories of injury, grief, and desperation and converted them into data points. Sales calls. Dosage escalations. Expansion plans. Every broken back became a bar graph. Every relapse a new market segment.

They didn’t need to sell directly to users.
They sold to the system.
They sold to doctors, who sold to patients, who sold to dealers, who sold to corpses.

It was clean. Sanitized. FDA-labeled.
Until it wasn’t.

And even when the death toll rose, towns collapsed, morgues overflowed, and families shattered, the machine didn’t stop. It adapted.

Raise the dose.
Target new regions.
Shift the blame.
Launch another campaign.
Make another statement.
Cash another check.

This wasn’t capitalism gone wrong.
This was capitalism doing exactly what it was trained to do.

The Sacklers didn’t break the system.
They followed it to its logical conclusion.

Maximize shareholder value.
Exploit legal ambiguity.
Protect the brand.
Externalize the cost.

And if the product kills?

Make sure it kills slowly.
Make sure it kills quietly.
Make sure the paperwork’s clean.

This is what they built.

Not a drug.
Not a dynasty.
A model.

One that will be copied, has been copied, and will outlive them all.

Because OxyContin was just the proof of concept.

The next version won’t have a family name.
It won’t come with a label.
It won’t show up in court.

It’ll be more efficient.
More optimized.
Harder to trace.

And when it hits?

We’ll call it something else.